The global biotechnology market is expected to grow at a rate of 13-15% over the next five years. Key drivers of this growth ...
The global animal biotechnology market size is calculated at USD 30.97 billion in 2025 and is expected to reach around USD 72.6 billion by 2034, growing at a CAGR of 9.93% for the forecasted ...
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
Touching Base is the dynamic podcast series from the editors of GEN. Each episode features a rotating case of senior editors—including John Sterling, Kevin Davies, Julianna LeMieux, Alex Phillippidis, ...
Interesting Engineering on MSN
New plant system triggers crops to grow themselves with genetic upgrades
Graduate student Arjun Ojha Kshetry and colleagues combined two key genes: WIND1, which reprograms cells near a wound, and ...
UK and ASEAN Strengthen Collaboration on Responsible Engineering Biology for a Sustainable Bioeconomy Bangkok, 10 November 2025 - The United Kingdom ...
Hosted on MSN
Biotechnology vs. Biomedical Engineering: Which degree is better for a future in healthcare tech?
As healthcare technology accelerates across the globe, students are increasingly drawn to two interdisciplinary fields at the cutting edge of innovation: biotechnology and biomedical engineering. Both ...
News-Medical.Net on MSN
Researchers use genetic engineering to create “product-ready” snakebite antivenom
An international team of researchers has used genetic engineering to create the first ever “product-ready” antivenom for ...
A federal judge in California has vacated USDA’s 2020 rule exempting genetically engineered plants from regulation, which could significantly delay approval of crops engineered with traits to resist ...
The positions in the table below reflect the National Institute for Genetic Engineering and Biotechnology (NIGEB)'s position overall, domestically, within their sector, and in various subject areas ...
Sarepta Therapeutics said it received approval from the Food & Drug Administration to update prescribing information for Elevidys, its gene therapy for Duchenne muscular dystrophy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results